⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5426324 | 0.85 | TSHR (0.32) | — | |
| SCHEMBL21829908 | 0.83 | — | — | |
| SCHEMBL584838 | 0.82 | TSHR (0.37) | — | |
| SCHEMBL5419554 | 0.80 | TSHR (0.31) | — | |
| SCHEMBL5418526 | 0.79 | TSHR (0.32) | — | |
| SCHEMBL473625 | 0.78 | — | — | |
| SCHEMBL5423967 | 0.76 | TSHR (0.41) | — | |
| SCHEMBL343237 | 0.76 | — | — | |
| SCHEMBL29407644 | 0.76 | — | — | |
| SCHEMBL303389 | 0.76 | TSHR (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239775-A1 | FXR REGULATOR, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | BEIJING BEST PATHWAY MANAGEMENT CONSULTING CENTER (LIMITED PARTNERSHIP) (CN) | 2024-07-18 | — | — | US | disclosed |
| US-20240239775-A1 | FXR REGULATOR, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | BEIJING BEST PATHWAY MANAGEMENT CONSULTING CENTER (LIMITED PARTNERSHIP) (CN) | 2024-07-18 | — | — | US | disclosed |
| US-20230357259-A1 | BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-11-09 | — | — | US | disclosed |
| US-20230357259-A1 | BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-11-09 | — | — | US | disclosed |
| US-11718620-B2 | Method for treating a cancer mediated by abnormality of multi-kinases | TRANSTHERA SCIENCES (NANJING), INC. (CN) | 2023-08-08 | — | — | US | disclosed |
| US-11718620-B2 | Method for treating a cancer mediated by abnormality of multi-kinases | TRANSTHERA SCIENCES (NANJING), INC. (CN) | 2023-08-08 | — | — | US | disclosed |
| WO-2023131277-A1 | NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF | 药捷安康(南京)科技股份有限公司 | 2023-07-13 | — | — | WO | disclosed |
| EP-3452484-B1 | CERTAIN PROTEIN KINASE INHIBITORS | FOCHON PHARMACEUTICALS LTD (CN) | 2023-07-05 | — | — | EP | disclosed |
| WO-2023104074-A1 | NEW USE OF KINASE INHIBITOR | 药捷安康(南京)科技股份有限公司 | 2023-06-15 | — | — | WO | disclosed |
| US-20230174556-A1 | COMPOUNDS AS PROTEIN KINASE INHIBITORS | FOCHON BIOSCIENCES, LTD. (CN) | 2023-06-08 | — | — | US | disclosed |
| EP-2738156-A1 | 9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUND | KBP Biosciences Co., Ltd. (CN) | 2014-06-04 | — | — | EP | disclosed |
| US-20140128331-A1 | C-GLYCOSIDE DERIVATIVES | Xuanzhu Pharma Co., Ltd. (CN) | 2014-05-08 | — | — | US | disclosed |
| US-20140128331-A1 | C-GLYCOSIDE DERIVATIVES | Xuanzhu Pharma Co., Ltd. (CN) | 2014-05-08 | — | — | US | disclosed |
| EP-2725031-A1 | C-GLYCOSIDE DERIVATIVES | Xuanzhu Pharma Co., Ltd. (CN) | 2014-04-30 | — | — | EP | disclosed |
| WO-2014023083-A1 | PI3Kδ INHIBITOR | 山东亨利医药科技有限责任公司 (CN) | 2014-02-13 | — | — | WO | disclosed |
| WO-2013044865-A1 | OXAZOLIDINONE ANTIBIOTICS CONTAINING FUSED RING | 山东轩竹医药科技有限公司 (CN) | 2013-04-04 | — | — | WO | disclosed |
| WO-2013013504-A1 | TIGECYCLINE DERIVATIVE | 山东亨利医药科技有限责任公司 (CN) | 2013-01-31 | — | — | WO | disclosed |
| WO-2013013505-A1 | 9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUND | 山东亨利医药科技有限责任公司 (CN) | 2013-01-31 | — | — | WO | disclosed |
| WO-2013010382-A1 | HETEROCYCLIC SUBSTITUTED PYRIMIDINE COMPOUND | 山东亨利医药科技有限责任公司 (CN) | 2013-01-24 | — | — | WO | disclosed |
| WO-2012167606-A1 | PYRIDONAPHTHYRIDINE PI3K/MTOR DUAL INHIBITORS AND PREPARATION AND USE THEREOF | 山东亨利医药科技有限责任公司 (CN) | 2012-12-13 | — | — | WO | disclosed |